| Fund ID | 805-3936541077 |
| Fund type | Hedge Fund |
| 3(c)(1) exclusion | No |
| 3(c)(7) exclusion | Yes |
| Master fund | Yes |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | Yes |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | No |
| % of assets independently valued | 100% |
| Owned by the adviser or related persons | 7% |
| Owned by funds of funds | 0% |
| Owned by non-U.S. persons | 78% |
| Fund | Type | Gross assets |
|---|---|---|
| Janus Henderson Cash Liquidity Fund LLC | Liquidity | $3.28B |
| Janus Henderson Core Plus Fixed Income Fund LLC | Other Private | $864.1M |
| Janus Henderson Multi-Strategy Master Fund Ltd. | Hedge | $700.1M |
Janus Henderson Biotech Innovation Master Fund Ltd. reports $2.1 billion in gross assets, among the top 3% of private funds by size.
The stated minimum investment is $1 million.
Janus Henderson Biotech Innovation Master Fund Ltd. is managed by Janus Henderson Investors US LLC.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.